Epigenetics
Overview
Epigenetics refers to heritable changes in gene expression that occur without alterations to the underlying DNA sequence. This chapter covers three phenomena (X-inactivation, genomic imprinting, and uniparental disomy) that are among the most conceptually challenging and clinically central topics in this area. These mechanisms explain why the same genetic change can produce different clinical outcomes depending on its parent of origin or cellular context.
Epigenetic mechanisms are clinically important because they affect genetic counseling in ways that go beyond simple Mendelian predictions. A deletion on chromosome 15q11-q13 causes Prader-Willi syndrome when inherited from the father but Angelman syndrome when inherited from the mother: the DNA change is the same, but the phenotype depends entirely on which parent contributed the affected chromosome. Similarly, X-inactivation explains why female carriers of X-linked conditions can show a spectrum of clinical involvement rather than being uniformly unaffected.
Working up an imprinting disorder routinely requires integrating multiple skills: determining the mechanism underlying a diagnosis (deletion vs. UPD vs. imprinting center defect), calculating recurrence risk based on that mechanism, and selecting the appropriate diagnostic test (methylation analysis vs. microarray vs. sequencing).
Key Concepts
- Parent-of-origin effects: why the same genetic change causes different phenotypes depending on maternal vs. paternal origin
- Methylation as a diagnostic tool: methylation-specific PCR and methylation arrays as first-line tests for imprinting disorders
- Recurrence risk varies by mechanism: deletion, UPD, imprinting center defect, and point mutation each carry different recurrence risks for the same condition
- Skewed X-inactivation: how non-random inactivation can cause symptomatic female carriers of X-linked conditions
- UPD detection: microsatellite analysis or SNP arrays to identify isodisomy vs. heterodisomy
Dosage Compensation
X-Inactivation covers the Lyon hypothesis, random X-inactivation in early embryonic development, and its clinical consequences. XIST drives the choice and silencing; subsequent maintenance is largely methylation-based. The distinction between random and skewed inactivation explains the spectrum of clinical involvement in female carriers of X-linked conditions and ties back to the X-Linked Inheritance leaf.
Foundations
Epigenetic mechanisms introduces the molecular machinery that regulates gene expression without altering DNA sequence: DNA methylation (5-methylcytosine at CpG sites), histone modifications (acetylation, methylation), chromatin accessibility, and non-coding RNAs. This is the foundation that the rest of the chapter builds on, and it connects directly to the Molecular Genetics chapter's coverage of gene regulation.
Parent-of-Origin Effects
Genomic imprinting is the mechanism by which certain genes are expressed from only one parental allele. The two clinically dominant regions are 15q11-q13 (Prader-Willi, Angelman) and 11p15.5 (Beckwith-Wiedemann, Silver-Russell). Methylation analysis is the first-line test because it detects all major molecular mechanisms (deletion, UPD, imprinting center defect) in a single assay.
Uniparental disomy (UPD) is the inheritance of both copies of a chromosome (or segment) from one parent. It causes disease two ways: disrupting imprinted gene expression (Prader-Willi/Angelman from UPD15, BWS from UPD11) and unmasking recessive alleles through isodisomy. Trisomy rescue is the most common origin, tying UPD back to the Cell Biology chapter's coverage of nondisjunction.
Together these three subsections explain some of the most nuanced aspects of clinical genetics practice.